Passive Equities

First Trust Capital Strength ETF

The First Trust Capital Strength® ETF (the “Fund”) seeks investment results that correspond generally to the price and yield (before the Fund’s fees and expenses) of an equity index called The Capital StrengthTM Index (the “Index”).

$98.00

Key Metrics

TER 0.53% per year
Distribution policy Distributing
Fund size USD 7,646 M
Inception date July 6, 2006
Holdings 52
Fund currency USD
Fund domicile US
Provider First Trust
For full official fund details, factsheets, and holdings, visit ftportfolios.com (opens in new tab).

Compare similar ETFs

Fund Size
Dividend
Fees
Current
Capital Strength ETF FTCS
Fund Size
$7.65B
Dividend
1.1%
Fees
0.53%
Morningstar Total Stock Market Index Fund VTI
Fund Size
$2.3T
Dividend
1.0%
Fees
0.03%
Morningstar Total Stock Market Index Fund VTSAX
Fund Size
$2.3T
Dividend
1.0%
Fees
0.04%
500 Index Fund VFIAX
Fund Size
$1.67T
Dividend
1.0%
Fees
0.04%
500 Index Fund VFINX
Fund Size
$1.67T
Dividend
0.9%
Fees
-
View 1341 similar ETFs →

Historical Return

Last updated: Sep 01, 2026
1 Year +8.2% +1.1% Div
3 Years (avg.) +9.6% +1.1% Div
5 Years (avg.) +4.8% +1.1% Div

Risk & Analysis Metrics

Last updated: Sep 01, 2026

Volatility

9.96% 1 Year
11.13% 3 Years
13.01% 5 Years
15.42% 10 Years

Max Drawdown

-8.02% 1 Year
-13.22% 3 Years
-21.63% 5 Years
-31.93% 10 Years

Sharpe Ratio

0.33 1 Year
0.45 3 Years
0.08 5 Years
0.38 10 Years

Return Triangle (Heatmap)

Last updated: Sep 01, 2026
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
2011 -5.6% 2.1% 10.8% 11.8% 9.4% 9.3% 11.3% 9.0% 10.7% 10.7% 12.1% 10.1% 9.8% 9.8% 9.5%
2012 10.5% 20.1% 18.2% 13.5% 12.5% 14.4% 11.3% 13.0% 12.7% 14.1% 11.6% 11.2% 11.1% 10.7%
2013 30.6% 22.3% 14.5% 13.0% 15.2% 11.4% 13.3% 13.0% 14.5% 11.7% 11.3% 11.1% 10.7%
2014 14.6% 7.3% 7.7% 11.6% 7.9% 10.7% 10.7% 12.6% 9.8% 9.5% 9.5% 9.2%
2015 0.4% 4.4% 10.7% 6.3% 9.9% 10.1% 12.4% 9.2% 9.0% 9.0% 8.7%
2016 8.6% 16.2% 8.4% 12.4% 12.1% 14.5% 10.5% 10.1% 10.0% 9.6%
2017 24.3% 8.3% 13.7% 13.0% 15.7% 10.9% 10.3% 10.2% 9.7%
2018 -5.7% 8.7% 9.5% 13.7% 8.4% 8.1% 8.3% 8.0%
2019 25.4% 18.0% 21.0% 12.2% 11.1% 10.9% 10.1%
2020 11.0% 18.8% 8.1% 7.8% 8.2% 7.8%
2021 27.2% 6.7% 6.8% 7.5% 7.2%
2022 -10.4% -2.1% 1.6% 2.7%
2023 7.0% 8.2% 7.4%
2024 9.5% 7.7%
2025 5.9%

Distributions

*by ETF Portfolio Weight Last updated: Sep 01, 2026

Profit Margin Distribution

< 0%
2%
1y 3y N/A N/A
0 - 5%
6%
1y 3y N/A N/A
5 - 10%
14%
1y 3y N/A N/A
10 - 15%
29%
1y 3y N/A N/A
15 - 20%
2%
1y 3y N/A N/A
20 - 30%
34%
1y 3y N/A N/A
30 - 40%
8%
1y 3y N/A N/A
> 40%
6%
1y 3y N/A N/A

P/E Ratio Distribution

< 0
2%
1y 3y N/A N/A
0 - 10
4%
1y 3y N/A N/A
10 - 15
11%
1y 3y N/A N/A
15 - 20
14%
1y 3y N/A N/A
20 - 25
26%
1y 3y N/A N/A
25 - 35
26%
1y 3y N/A N/A
35 - 50
14%
1y 3y N/A N/A
> 50
2%
1y 3y N/A N/A

Discounted Cash Flow

Weighted Average Undervaluation
N/A
Undervalued
> 60%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
15 - 30%
0%
1y 3y N/A N/A
Fair (&plusmn;15%)
0%
1y 3y N/A N/A
Overvalued
15 - 30%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
> 60%
0%
1y 3y N/A N/A

Market Cap Size Distribution

Micro Cap
0.0%
1y 3y N/A N/A
Small Cap
0.0%
1y 3y N/A N/A
Mid Cap
0.0%
1y 3y N/A N/A
Large Cap
73.2%
1y 3y N/A N/A
Mega Cap
26.8%
1y 3y N/A N/A
Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B

Portfolio Concentration

*by ETF Portfolio Weight Last updated: Sep 01, 2026
12.1% Top 5 Holdings
23.1% Top 10 Holdings
100.0% Top 50 Holdings
100.0% Top 100 Holdings
Top 5 Companies
EOG EOG Resources, Inc.
2.8%
LIN Linde Plc
2.3%
ROST Ross Stores, Inc.
2.3%
JNJ Johnson & Johnson
2.3%
GILD Gilead Sciences, Inc.
2.3%

Latest News

6 days ago • zacks.com

Johnson & Johnson (JNJ) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Johnson & Johnson (JNJ) reached $269.12 at the closing of the latest trading day, reflecting a -2.22% change compared to its last close.

6 days ago • fool.com

Does iShares Pharma ETF Offer Superior Returns to Invesco's Equal Weight Healthcare Fund?

IHE's concentrated pharma holdings delivered 50% returns over one year, while RSPH's equal-weight healthcare approach generated 29%. Risk profiles ...

7 days ago • fool.com

Is the iShares Pharmaceuticals ETF or iShares Healthcare ETF the Better Fund for 2026?

IHE's concentrated pharma focus delivered 50% gains versus IYH's 27.4%, though the broader healthcare fund offers more diversification and $3.9B in...

Average metrics of all companies in portfolio

Last updated: Sep 13, 2026
Market
Average
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $428B -
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 1.66% 2.01%
Beta Indicates the relationship between the price performance of a share and the market. 0.73 -
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 26.75 22.99
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -55.28 -
Profitable Companies 98% -
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 30.03 18.8
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 5.35 9.13
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 14.31 11.88
Market
Average
Enterprise Value to EBIT Enterprise Value divided by EBIT 18.32 12.43
Enterprise Value to Revenue Enterprise value divided by revenue 5.49 12.4
Total Debt to Enterprise Value Total debt divided by enterprise value 0.11 0.04
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 2.01 0.32
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 19.67% 21.44%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. +31.8% +54.3%
Return on Equity Equity divided by market cap. 42.99% 2.03%
Return on Assets Indicates a company's profitability in relation to its total assets. 11.83% 4.04%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 23.07% 3.73%

Sectors

Manufacturing 39.6%
Finance and Insurance 14.2%
Retail Trade 11.2%
Information 10.3%
Professional, Scientific, and Technical Services 4.3%
Transportation and Warehousing 2.2%
Finance 2.1%
Other Services (except Public Administration) 2.1%
Management of Companies and Enterprises 2.1%
Mining, Quarrying, and Oil and Gas Extraction 2.0%
Construction 2.0%
Industrials 1.9%
Wholesale Trade 1.7%
Other 4.2%

Countries

United States 94.0%
Switzerland 4.1%
United Kingdom 1.8%
Other 0.1%

Stock Screener

Select filters to narrow down the 51 investments below

51 companies

Limit holdings to companies in a single sector.

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap $441.95B
P/E Ratio 33.4
Dividends 1.5%
Total Investment $209.77M
Weight 2.74%

Loading details…

Market Cap $84.89B
P/E Ratio 39.8
Dividends 0.0%
Total Investment $192.98M
Weight 2.52%

Loading details…

Market Cap $22.77B
P/E Ratio 10.7
Dividends 4.8%
Total Investment $180.57M
Weight 2.36%

Loading details…

Market Cap $107.23B
P/E Ratio 24.5
Dividends 2.5%
Total Investment $172.08M
Weight 2.25%

Loading details…

Market Cap $26.06B
P/E Ratio 8.0
Dividends 2.1%
Total Investment $170.95M
Weight 2.24%

Loading details…

Loading details…

Market Cap $640.02B
P/E Ratio 30.7
Dividends 2.0%
Total Investment $167.05M
Weight 2.18%

Loading details…

Market Cap $168.96B
P/E Ratio 23.0
Dividends 2.0%
Total Investment $166.83M
Weight 2.18%

Loading details…

Market Cap $691.65B
P/E Ratio 31.5
Dividends 0.7%
Total Investment $166.7M
Weight 2.18%

Loading details…

Market Cap $355.49B
P/E Ratio 114.2
Dividends 2.3%
Total Investment $166.23M
Weight 2.17%

Loading details…

Market Cap $379.87B
P/E Ratio 26.5
Dividends 2.4%
Total Investment $165.28M
Weight 2.16%

Loading details…

Market Cap $4.88T
P/E Ratio 37.9
Dividends 0.3%
Total Investment $164.94M
Weight 2.16%

Loading details…

Loading details…

Market Cap $69.46B
P/E Ratio 34.1
Dividends 2.4%
Total Investment $164.57M
Weight 2.15%

Loading details…

Market Cap $26.02B
P/E Ratio 14.3
Dividends 2.7%
Total Investment $163.78M
Weight 2.14%

Loading details…

Loading details…

Market Cap $215.67B
P/E Ratio 30.0
Dividends 1.4%
Total Investment $162.39M
Weight 2.12%

Loading details…

Market Cap $96.29B
P/E Ratio 21.4
Dividends 1.7%
Total Investment $162.26M
Weight 2.12%

Loading details…

Market Cap $85.07B
P/E Ratio 29.1
Dividends 1.9%
Total Investment $161.37M
Weight 2.11%

Loading details…

Market Cap $4.1T
P/E Ratio 16.7
Dividends 0.3%
Total Investment $161.11M
Weight 2.11%

Loading details…